Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: GLAXOSMITHKLINE, LLC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2021-11-15 to 2022-12-30
Current total value of award: $1596201996
Description: :COVID-19: SOTROVIMAB OPTION PERIOD 2001/3001 INTENT/EXERCISE DATE CHANGE.